Company Filing History:
Years Active: 2019
Title: Innovations of Shuai Miao in Pharmaceutical Development
Introduction
Shuai Miao is a notable inventor based in Taizhou, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of inhibitors for fibroblast growth factor receptors. His work is characterized by a focus on innovative chemical compounds that have therapeutic potential.
Latest Patents
Shuai Miao holds a patent for "Substituted pyrazoles as inhibitors of fibroblast growth factor receptor." This patent details an indole derivative expressed by Formula (I), along with its preparation method, pharmaceutical salt, and its use as a therapeutic agent, especially as an FGFR inhibitor. Each substituent in Formula (I) is defined as specified in the patent specification.
Career Highlights
Miao is currently employed at Zhejiang Hisun Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work at this company has positioned him as a key player in the pharmaceutical industry, contributing to the development of innovative treatments.
Collaborations
Shuai Miao collaborates with talented coworkers, including Lei Chen and Dongliang Guan. Their combined expertise enhances the research and development capabilities within their organization.
Conclusion
Shuai Miao's contributions to pharmaceutical innovation, particularly through his patent on FGFR inhibitors, highlight his role as a significant inventor in the field. His ongoing work at Zhejiang Hisun Pharmaceutical Co., Ltd. continues to pave the way for advancements in therapeutic agents.